Taiyo Kagaku CoNGO:2902 +0.58%76 EBITDA Margin % is 18.60% as of Mar. 2026, which is 34% above its 10-year median of 13.90. GuruFocus rates NGO:2902 with a GF Score™ of 76/100 and a GF Value™ of 円1,866.26 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 1,574 Chemicals companies, Taiyo Kagaku Co ranks better than 77.89% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Taiyo Kagaku Co's EBITDA for the
six
months ended in Mar. 2026 was 円4,921 Mil. Taiyo Kagaku Co's Revenue for the
six
months ended in Mar. 2026 was 円26,460 Mil. Therefore, Taiyo Kagaku Co's EBITDA margin for the quarter that ended in Mar. 2026 was 18.60%.
Taiyo Kagaku Co (NGO:2902) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Taiyo Kagaku Co EBITDA Margin % Related Terms
Taiyo Kagaku Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Taiyo Kagaku Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGO:2902 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Taiyo Kagaku Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyo Kagaku Co EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Taiyo Kagaku Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Taiyo Kagaku Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiyo Kagaku Co (NGO:2902) has a EBITDA Margin % of 18.60% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Taiyo Kagaku Co and its competitors. This is 34% above median its historical median of 13.90. Over the past decade, Taiyo Kagaku Co's EBITDA Margin % has ranged from 10.54 to 18.19. According to the industry distribution chart, Taiyo Kagaku Co ranks #348 out of 1574 companies in the Chemicals industry, placing it in the top 22.1%.
Is Taiyo Kagaku Co's EBITDA Margin % too high?
Taiyo Kagaku Co's current EBITDA Margin % of 18.60% is 34% above median its 10-year median of 13.90. Over the past 10 years, this metric has ranged from a low of 10.54 to a high of 18.19. The Chemicals industry median EBITDA Margin % is 9.64. Taiyo Kagaku Co's value of 18.60% is 93% above this industry median. Based on the distribution chart, Taiyo Kagaku Co ranks #348 out of 1574 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Taiyo Kagaku Co has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Taiyo Kagaku Co's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Taiyo Kagaku Co ranks #348 out of 1574 companies for EBITDA Margin %. This places Taiyo Kagaku Co in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. Taiyo Kagaku Co's value of 18.60% is 93% above this benchmark. Historically, Taiyo Kagaku Co's own EBITDA Margin % has ranged from 10.54 to 18.19 over the past decade. While the company's 10-year median is 13.90 vs. the industry median of 9.64, Taiyo Kagaku Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,574 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyo Kagaku Co's current EBITDA Margin % of 18.60% is 93% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Taiyo Kagaku Co and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyo Kagaku Co's current EBITDA Margin % is 18.60%, which is 34% above median its own 10-year median of 13.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyo Kagaku Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyo Kagaku Co (NGO:2902) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,866.26, compared to a current price of 円2,796.00 — trading 49.8% above its estimated fair value. The current EBITDA Margin % is 18.60%, which is 34% above median its 10-year median of 13.90 and 93% above the Chemicals industry median of 9.64. Taiyo Kagaku Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Taiyo Kagaku Co (NGO:2902), the current EBITDA Margin % is 18.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyo Kagaku Co (NGO:2902) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyo Kagaku Co stock appears to be overvalued.
The current stock price of 円2,796.00 is trading 49.8% above its estimated GF Value™ of 円1,866.26.
GuruFocus considers Taiyo Kagaku Co to be Significantly Overvalued.
Key valuation signals for NGO:2902:
EBITDA Margin %: 18.60% (34% above median its 10-year median of 13.90)
GF Value™: 円1,866.26 vs. price of 円2,796.00 (49.8% above fair value)
Industry Position: 93% above the Chemicals median (#348 of 1574)
No single metric tells the full story. See the NGO:2902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyo Kagaku Co Ltd is based in Japan. The company has three reportable segments: the Nutrition Business, the Interface Solutions Business, and the Natural Ingredients Business. The Nutrition Business manufactures and sells functional food ingredients such as catechin (green tea extract), theanine (a functional amino acid), and water-soluble dietary fiber, as well as mineral and vitamin preparations. The Interface Solutions Business manufactures and sells quality improvers such as emulsifiers. The Natural Ingredients Business manufactures and sells food ingredients such as egg products, protein ingredients, ingredients for instant foods, and processed agricultural products, as well as quality improvers and stabilizers.
76GF Score
Get the complete analysis for NGO:2902
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGO:2902 has been successfully added to your 
